PRRT2 and breast cancer: Simultaneously, acquired endocrine resistance in HR+ BC is accompanied by an intense GPER-induced intracellular Ca2+ mobilization,72,93 and estrogen regulates the Hippo signaling via the GPER/PLC/PKC pathway to enhance breast tumorigenesis.161